The state of Florida currently has 27 active clinical trials seeking participants for Type 2 Diabetes research studies. These trials are conducted in various cities, including Miami, Tampa, Jacksonville and Orlando.
Pharmacist-led Continuous Glucose Monitoring
Recruiting
This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with type 2 diabetes. The main questions it aims to answer are: 1. to assess change in hemoglobin A1c in people with type 2 diabetes using continuous glucose monitoring under a pharmacist-led approach as compared to a pharmacist-led approach utilizing no continuous glucose monitoring (only self-monitoring... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/26/2024
Locations: USF Health Department of Family Medicine - Morsani Center for Advanced Health Care, Tampa, Florida +1 locations
Conditions: Type 2 Diabetes
PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG
Recruiting
To evaluate the proportion of diabetic mellitus patients with CV events as measured by HEMOTAG.
Gender:
ALL
Ages:
40 years and above
Trial Updated:
08/21/2024
Locations: Metabolic Research Institute, Inc, West Palm Beach, Florida
Conditions: Diabetes Mellitus Type 2, Cardiovascular Diseases, Coronary Artery Disease, Cerebrovascular Disease, Peripheral Artery Disease
RESET System Pivotal Trial (Rev F)
Recruiting
A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Evaluating the RESET System for Glycemic Improvement in Patients with Inadequately Controlled Type 2 Diabetes and Obesity, the STEP-1 Study. A multi-center, double-blinded, randomized, sham-controlled trial to evaluate the safety and effectiveness of the RESET System plus moderate intensity lifestyle and dietary counseling compliant with 2024 ADA Standard of Care as compared to a sham control receiving moderate intensity lifestyle an... Read More
Gender:
ALL
Ages:
Between 22 years and 65 years
Trial Updated:
07/16/2024
Locations: University of Miami Hospital, Miami, Florida
Conditions: Diabetes type2, Obesity